ICON Public Limited Company
ICLRNASDAQHealthcare● Active
$151.32
+$1.87(+1.25%)
Market Cap$11.6B
P/E Ratio—
52W High$211
52W Low$66.57
ICON Public Limited Company (ICLR) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
ICLR · earnings · updated Jun 8, 2026
Latest Earnings
Q4 FY2025Report Date: Oct 22, 2025EPS Actual
$3.31
Est. $3.28 · +0.9%
Revenue
$2.04B
Est. $1.98B · +3.0%
Fiscal Period
Q4 FY2025
FY ends December
Report Date
Oct 22, 2025
After Market Close
▲ Beat Revenue🔥 4-Quarter EPS Beat Streak
ICLR reports quarterly as a NASDAQ-listed Medical - Diagnostics & Research company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.07
Rev. $15.39B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.07
Rev. Est.$15.39B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Jul 22, 2026 | $3.01 | — | — | — | $1.95B | — |
| ◌ Q2 FY2026 | Jun 10, 2026 | $2.47 | — | — | — | $1.99B | — |
| — Q4 FY2025 | Oct 22, 2025 | $3.28 | $3.31 | +0.9% | $2.04B | $1.98B | +3.0% |
| ▲ Q3 FY2025 | Jul 23, 2025 | $3.19 | $3.26 | +2.2% | $2.02B | $1.98B | +1.8% |
| ▲ Q2 FY2025 | Apr 30, 2025 | $3.11 | $3.19 | +2.6% | $2.00B | $2.01B | -0.3% |
| — Q1 FY2025 | Feb 19, 2025 | $3.41 | $3.43 | +0.6% | $2.04B | $2.04B | +0.2% |
| ▼ Q4 FY2024 | Oct 23, 2024 | $3.85 | $3.35 | -13.0% | $2.03B | $2.13B | -4.9% |
| ▲ Q3 FY2024 | Jul 24, 2024 | $3.68 | $3.75 | +1.9% | $2.12B | $2.14B | -0.8% |
Q3 FY2026
Jul 22, 2026
EPS Actual
—
EPS Est.
$3.01
EPS Surpr.
—
Revenue
—
Q2 FY2026
Jun 10, 2026
EPS Actual
—
EPS Est.
$2.47
EPS Surpr.
—
Revenue
—
Q4 FY2025
Oct 22, 2025
EPS Actual
$3.31
EPS Est.
$3.28
EPS Surpr.
+0.9%
Revenue
$2.04B
Q3 FY2025
Jul 23, 2025Beat
EPS Actual
$3.26
EPS Est.
$3.19
EPS Surpr.
+2.2%
Revenue
$2.02B
Q2 FY2025
Apr 30, 2025Beat
EPS Actual
$3.19
EPS Est.
$3.11
EPS Surpr.
+2.6%
Revenue
$2.00B
Q1 FY2025
Feb 19, 2025
EPS Actual
$3.43
EPS Est.
$3.41
EPS Surpr.
+0.6%
Revenue
$2.04B
Q4 FY2024
Oct 23, 2024Miss
EPS Actual
$3.35
EPS Est.
$3.85
EPS Surpr.
-13.0%
Revenue
$2.03B
Q3 FY2024
Jul 24, 2024Beat
EPS Actual
$3.75
EPS Est.
$3.68
EPS Surpr.
+1.9%
Revenue
$2.12B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2029 | $5.28 | $5.36 | $5.41 | 6 |
| Q3 FY2029 | $5.12 | $5.20 | $5.25 | 3 |
| Q2 FY2029 | $4.87 | $4.95 | $5.00 | 5 |
| Q1 FY2029 | $4.73 | $4.80 | $4.84 | 3 |
| Q4 FY2028 | $3.30 | $3.35 | $3.38 | 7 |
| Q3 FY2028 | $3.20 | $3.25 | $3.28 | 4 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2029 | $2.3B | $2.4B | $2.4B | 3 |
| Q3 FY2029 | $2.3B | $2.3B | $2.3B | 3 |
| Q2 FY2029 | $2.2B | $2.3B | $2.3B | 3 |
| Q1 FY2029 | $2.2B | $2.2B | $2.3B | 5 |
| Q4 FY2028 | $2.1B | $2.2B | $2.2B | 4 |
| Q3 FY2028 | $2.1B | $2.1B | $2.2B | 4 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q4 FY2025 | Oct 22, 2025 | +0.9% | $193.26 | $192.60 | -0.34% |
| ▲ Q3 FY2025 | Jul 23, 2025 | +2.2% | $161.50 | $167.89 | +3.96% |
| ▲ Q2 FY2025 | Apr 30, 2025 | +2.6% | $149.31 | $151.44 | +1.43% |
| ▲ Q1 FY2025 | Feb 19, 2025 | +0.6% | $188.65 | $191.32 | +1.42% |
| ▼ Q4 FY2024 | Oct 23, 2024 | -13.0% | $283.49 | $280.76 | -0.96% |
| ▲ Q3 FY2024 | Jul 24, 2024 | +1.9% | $332.23 | $331.77 | -0.14% |
| ▲ Q2 FY2024 | Apr 24, 2024 | +1.8% | $306.45 | $309.44 | +0.98% |
| ▲ Q1 FY2024 | Feb 21, 2024 | +0.6% | $283.48 | $284.70 | +0.43% |
Q4 FY2025-0.34%
Report Date
Oct 22, 2025
EPS Beat/Miss
+0.9%
Price Before
$193.26
Price After
$192.60
Q3 FY2025+3.96%
Report Date
Jul 23, 2025
EPS Beat/Miss
+2.2%
Price Before
$161.50
Price After
$167.89
Q2 FY2025+1.43%
Report Date
Apr 30, 2025
EPS Beat/Miss
+2.6%
Price Before
$149.31
Price After
$151.44
Q1 FY2025+1.42%
Report Date
Feb 19, 2025
EPS Beat/Miss
+0.6%
Price Before
$188.65
Price After
$191.32
Q4 FY2024-0.96%
Report Date
Oct 23, 2024
EPS Beat/Miss
-13.0%
Price Before
$283.49
Price After
$280.76
Q3 FY2024-0.14%
Report Date
Jul 24, 2024
EPS Beat/Miss
+1.9%
Price Before
$332.23
Price After
$331.77
Q2 FY2024+0.98%
Report Date
Apr 24, 2024
EPS Beat/Miss
+1.8%
Price Before
$306.45
Price After
$309.44
Q1 FY2024+0.43%
Report Date
Feb 21, 2024
EPS Beat/Miss
+0.6%
Price Before
$283.48
Price After
$284.70
Avg Beat Reaction+1.11%
Avg Miss Reaction-0.96%
Beat Rate7 / 8 quarters
Largest Move+3.96% (Q3 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: ICLR ends December
ICON Public Limited Company (ICLR) most recently reported earnings on October 22, 2025 for Q4 FY2025, posting EPS of $3.31 (in line with the analyst consensus of $3.28). ICLR has beaten EPS estimates for 4 consecutive quarters. The next ICLR earnings date is expected around September 1, 2026.
Each quarter, investors track ICLR earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. ICLR revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
ICLR's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
ICLR earnings · 4 questionsICON Public Limited Company's next earnings report is expected around September 1, 2026. ICLR typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; ICLR historically reports after market close (AMC).
ICLR earnings datewhen is ICLR earningsICLR next earnings datewhen does ICLR report earningsICLR earnings calendar
▸ Source: FMP · ICON Public Limited Company SEC filings · US GAAP · ICON Public Limited Company SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026